US Patent Issued to Ontario Institute for Cancer Research (OICR), University Health Network on April 29 for "Cancer risk based on tumour clonality" (Canadian Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,678, issued on April 29, was assigned to Ontario Institute for Cancer Research (OICR) (Toronto) and University Health Network (Toronto).

"Cancer risk based on tumour clonality" was invented by Shadrielle Melijah G. Espiritu (Kitchener, Canada), Yiyang Liu (Woodbridge, Canada), Paul C. Boutros (Toronto) and Robert G. Bristow (Toronto).

According to the abstract* released by the U.S. Patent & Trademark Office: "In an aspect, there is provided a method for diagnosing or prognosing a subject with cancer, the method comprising: providing cancer DNA sequencing data from a cancer sample comprising cancer DNA from the subject; comparing the cancer DNA sequencing data with control DNA sequ...